Since the racial reckoning triggered by the death of George Floyd in the summer of 2020, corporations have opened their checkbooks and flashed their woke credentials.
Two important reviews were recently released, both casting serious doubts on the scientific basis for many policies rolled out during the COVID-19 pandemic.
As the Biden administration pushes the Department of Health and Human Services to make “gender-affirming health care” more widely available, HHS’s own National Institutes of Health is funding multiple studies premised upon how little research has been conducted on the long-term risks of taking cross-sex hormones and whether they improve mental health.